Role of tumor necrosis factor alpha in induction of murine CD14 gene expression by lipopolysaccharide

Infection and Immunity

Volumn 65, Issue 11, 1997, Pages 4822-4831

  Fearns, Colleen ^a   Loskutoff, David J ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; FEMALE; GENE EXPRESSION; GENE INDUCTION; HYPOTHESIS; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IN SITU HYBRIDIZATION; MEMBRANE BINDING; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0030829208     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.65.11.4822-4831.1997     Document Type: Article

References (44)

1. Aderka, D., H. Engelmann, Y. Maor, C. Brakebusch, and D. Wallach. 1992. Stabilization of the bioactivity of tumor necrosis factor by its soluble receptor. J. Exp. Med. 175:323-329.
2. Ashkenazi, A., S. A, Marsters, D. J. Capon, S. M. Chamow, I. S. Figari, D. Pennica, D. V. Goeddel, M. A. Palladino, and D. H. Smith. 1991. Protection against endotoxic shock by a tumor necrosis factor receptor immunoadhesin. Proc. Natl. Acad. Sci. USA 88:10535-10539.
3. Bauss, F., W. Droge, and D. N. Mannel. 1987. Tumor necrosis factor mediates endotoxic effects in mice. Infect. Immun 55:1622-1625
4. Bone, R. C. 1991. The pathogenesis of sepsis. Ann. Intern Med. 115:457469.
5. Butler, L. D., N. K. Layman, R. L. Cain. P. E. Riedl, K. M. Mohler. J. L. Bobbitt, R. Belagajie, j. Sharp, and A. M. Bendele. 1989. Interleukin linduced pathophysiology: induction of cytokines, development of histopathologic changes, and immunopharmacologic intervention. Clin. Immunol. Immunopathol. 53:400-421.
6. Chensue, S. W., P. D. Terebuh, D. G. Remick, W. E. Scales, and S. L. Kunkel. 1991. In vivo biologic and immunohistochemical analysis of interleukin-1 alpha, beta and tumor necrosis factor during experimental endotoxcmia. Kinetics, Kupffer cell expression, and glucocorticoid effects. Am. J. Pathol. 138:395-402.
7. Chomczynski, P., and N. Sacchi. 1987. Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159.
8. Endo, S., K. Inada, T. Kasai, T. Takakuwa, H. Nakae, M. Kikuchi, H. Yamashita, and M. Yoshida. 1994. Soluble CD14 (sCD14) levels in patients with multiple organ failure (MOF). Res. Commun. Chem. Pathol. Pharmacol. 84:17-25.
9. Fearns, C., V. V. Kravchenko, R. J. Ulevitch, and D. J. Loskutoff. 1995. Murine CD14 gene expression in vivo: extramyeloid synthesis and regulation by lipopolysaccharide. J. Exp. Med. 181:857-866.
10. Fong, Y., M. A. Marano, L. L. Moldawer, H. Wei, S. E. Calvano, J. S. Kenney, A. C. Allison, A. Cerami, G. T. Shires, and S. F. Lowry. 1990. The acute splanchnic and peripheral tissue metabolic response to endotoxin in humans. J. Clin. Invest. 85:1896-1904.
11. Fong, Y., K. J. Tracey, L. L. Moldawer, D. G. Hesse, K. B. Manogue, J. S. Kenney, A. T. Lee, G. C. Kuo, A. C. Allison, S. F. Lowry, et al. 1989. Antibodies to cachetin/tumor necrosis factor reduce interleukin Iβ and interleukin 6 appearance during lethal bacteremia. J. Exp. Med. 170:1627-1633.
12. Frey, E. A., D. S. Miller, T. G. Jahr, A. Sundan, V. Bazil, T. Espevik, B. B. Finlay, and S. D. Wright 1992. Soluble CD14 participates in the response of cells to lipopolysaccharide. J. Exp. Med. 176:1665-1671.
13. Giroir, B. P., J. H. Johnson, T. Brown, G. L. Allen, and B. Beutler. 1992. The tissue distribution of tumor necrosis factor biosynthesis during endotoxcmia. J. Clin. Invest. 90:693-698.
14. Golenbock, D. T., R. R. Bach, H. Lichenstein, T. S.-C. Juan, A. Tadavarthy, and C. F. Moldow. 1995. Soluble CD14 promotes LPS activation of CD14deficicnt PNH monocytes and endothelial cells. J. Lab. Clin. Med. 125:662671.
15. Grunwald, U., C. Krüger, and C. Schütt. 1993. Endotoxin-neutralizing capacity of soluble CD14 is a highly conserved specific function. Circ. Shock 39:220-225.
16. Mailman, E., H. S. Lichenstein, M. M. Wurfel, D. S. Miller, D. A. Johnson, M. Kelley, L. A. Busse, M. M. Zukowski, and S. D. Wright. 1994. Lipopoly saccharide (LPS)-binding protein accelerates the binding of LPS to CD14. J. Exp. Med. 179:269-277.
17. Hailman, E., T. Vasselon, M. Kelley, L. A. Busse, M. C.-T. Hu, H. S. Lichenstein, P. A. Detmers, and S. U. Wright. 1996. Stimulation of macrophages and neutrophils by complexes of lipopolysaccharide and soluble CD14. J. Immunol. 156:4384-4390.
18. Haziot, A, G.-W. Rong, V. Bazil, J. Silver, and S. M. Goyert. 1994. Recombinant soluble CD14 inhibits LPS-induced tumor necrosis factor-a production by cells in whole blood. J. Immunol. 152:5868-5876.
19. Haziot, A, G.-W. Rong, J. Silver, and S. M. Goyert. 1993. Recombinant soluble CD14 mediates the activation of endothelial cells by lipopolysaccharide. J. Immunol. 151:1500-1507.
20. Haziot, A., G. W. Rong, X.-Y. Lin, J. Silver, and S. M. Goyert. 1995. Recombinant soluble CD14 prevents mortaliry in mice treated with endotoxin (lipopolysaccharide). J. Immunol. 154:6529-6532.
21. Hoffmann, R., M. Grewe, H. C. Estler, A. Schulze-Specking, and K. Decker. 1994. Regulation of tumor necrosis factor-alpha-mRNA synthesis and distribution of tumor necrosis factor-alpha-mRNA synthesizing cells in rat liver during experimental endotoxemia. J. Hepatol. 20:122-128.
22. Hunt, J. S., H.-L. Chen, X.-L. Hu, T.-Y. Chen, and D. C. Morrison. 1992. Tumor necrosis factor-α gene expression in the tissues of normal mice. Cytokine 4:340-346.
23. Ikewaki, N., and H. Inoko. 1991. Induction of CD14 antigen on the surface of U937 cells by an interleukin-6 autocrine mechanism after culture with formalin-killed gram-negative bacteria. Tissue Antigens 38:117-123.
24. Jevnikar, A. M., R. P. Wuthrich, D. C. Brennan, W. Maslinski, L. H. Glimcher, and V. E. Rubin-Kelley. 1991. TNF-alpha is expressed on the surface of kidney proximal tubular cells. Transplant. Proc. 23:231-232.
25. Labeta, M. O., J.-J. Durieux, N. Fernandez, R. Herrmann, and P. Ferrara. 1993. Release from a human monocyte-like cell line of two different soluble forms of the lipopolysaccharide receptor, CD14. Eur. J. Immunol. 23:21442151.
26. Labeta, M. O., J.-J. Durieux, G. Spagnoli, N. Femandez, J. Wydenes, and R. Herrmann. 1993. CD14 and tolerance to lipopolysaccharidc: biochemical and functional analysis. Immunology 80:415-423.
27. LE, J., and J. Vilcek. 1987. Biology of disease. Tumor necrosis factor and interleukin 1: cytokines with multiple overlapping biological activities. Lab. Invest. 56:234-248.
28. Lorenz, H.-M., C. Antoni, T. Valerius, R. Repp, M. Grunke, N. Scbwerdtner, H. Nublein, J. Woody, and J. R. Kaldeo. 1996. In vivo blockade of TNF-α by intravenous infusion of a chimeric monoclonal TNF-α antibody with rheumatoid arthritis. J. Immunol. 156:1646-1653.
29. Luster, M. I., D. R. Germolec, T. Yoshida. F. Kayama, and M. Thompson. 1994. Endotoxin-induced cytokine gene expression and excretion in the liver. Hepatology 19:480-488.
30. Matsuura, K., T. Ishida, M. Setoguchi, Y. Higuchi, S. Akizuki, and S. Yamamoto. 1994. Upregulation of mouse CD14 expression in Kupffer cells by lipopolysaccharide. J. Exp. Med. 179:1671-1676.
31. Morrison, D. C., and R. J. Ulevitch. 1978. The effects of bacterial endotoxins on host mediation systems. Am. J. Pathol. 93:525-617.
32. Neumann, B., T. Machleidt, A. Lifka, K. Pfeffer, D. Vestweber, T. W. Mak, B. Holzmann, and M. Kronke. 1996. Crucial role of 55-kilodalton TNF receptor in TNF-induced adhesion molecule expression and leukocyte organ infiltration. J. Immunol. 156:1587-1593.
33. Pugin, J., C.-C. Schürer-Maly, D. Leturcq, A. Moriarty, R. J. Ulevitch, and P. S. Tobias. 1993. Lipopolysaccharide activation of human endothelial and epithelial cells is mediated by lipopolysaccharide-binding protein and soluble CD14. Proc. Natl. Acad. Sci. USA 90:2744-2748.
34. Read, M. A., S. R. Cordle, R. A. Veach, C. D. Carlisle, and J. Hawiger. 1993. Cell-free pool of CD14 mediates activation of transcription factor NF-κB by lipopolysaccharide in human endothelial cells. Proc. Natl. Acad. Sci. USA 90:9887-9891.
35. Schumann, R. R. 1992. Function of lipopolysaccharide (LPS)-binding protein (LBP) and CD 14, the receptor for LPS/LBP complexes: a short review. Res. Immunol. 143:11-15.
36. Schutt, C., T. Schilling, U. Grunwald, W. Schönfeld, and C. Krüger. 1992. Endotoxin-neutralizing capacity of soluble CD14. Res. Immunol. 143:71-78.
37. d and tumor necrosis factor receptor-deficient mice. Eur. J. Immunol. 26:2686-2692.
38. van Zee, K. J., T. Kohno, E. Fischer, C. S. Rock, L. L. Moldawer, and S. F. Lowry. 1992. Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor α in vitro and in vivo. Proc. Nail. Acad. Sci. USA 89:4845-4849.
39. Vogel, S. N. 1992. The Ips gene. Insights into the genetic and molecular basis of LPS responsiveness and macrophage differentiation, p. 485-513. In B. Beutler (ed.). Tumor necrosis factors: the molecules and their emerging role in medicine. Raven Press, Ltd., New York, N.Y.
40. Weingarten, R., L. A. Sklar, J. C. Mathison, S. Omidi, T. Ainsworth, S. Simon, R. J. Ulevitch, and P. S. Tobias. 1993. Interactions of lipopolysaccharide with neutrophils in blood via CD14. J. Leukocyte Biol. 53:518-524.
41. Wright, S. D., R. A. Ramos, A. Hennanowski-Vosatka, P. Rockwell, and P. A. Detmers. 1991. Activation of the adhesive capacity of CR3 on neutrophils by endotoxin: dependence on lipopolysaccharide binding protein and CD14. J. Exp. Med. 173:1281-1286.
42. Wright, S. D., R. A. Ramos, P. S. Tobias, R. J. Ulevitch, and J. C. Mathison. 1990. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 249:1431-1433.
43. Zanetti, G., D. Heumann, J. Gérain, J. Kohler, P. Abbet, C. Barras, R. Lucas, M.-P. Glauser, and J.-D. Baumgartner. 1992. Cytokine production after intravenous or peritoneal gram-negative bacterial challenge in mice. Comparative protective efficacy of antibodies to tumor necrosis factor-α and to lipopolysaccharide. J. Immunol. 148:1890-1897.
44. Ziegler-Heitbrock, H. W. L., and R. J. Ulevitch. 1993. CD14: cell surface receptor and differentiation marker. Immunol. Today 14:121-125.